Biotechnology at Ashland University

Starting salaries around $47,000—the typical outcome for biotechnology bachelor's programs nationally—would need to support estimated debt of $24,125 for Ashland's degree. That debt-to-earnings ratio of 0.51 means graduates would owe about half their first-year salary, which is manageable but not especially comfortable. For context, biotechnology programs nationally carry a median debt closer to $20,600, so this program appears to run about $3,500 higher than the typical biotechnology degree.

The challenge here is that we're working entirely with estimates—both the earnings and debt figures come from peer programs rather than Ashland's actual graduate outcomes. With only three biotechnology programs in Ohio and limited reporting across them, there's no clear state benchmark to gauge whether Ashland delivers competitive value within the region. The earnings estimate matches the national median almost exactly, suggesting neither advantage nor disadvantage compared to biotechnology degrees elsewhere, but that's based on an 18-program sample nationally, not this specific institution's track record.

Given the uncertainty, families should focus on whether Ashland offers concrete advantages that justify the investment: strong lab facilities, research opportunities, or industry connections that might accelerate career outcomes beyond what these peer-program estimates suggest. Without actual data showing how this program's graduates fare, you're essentially betting on Ashland's ability to match or exceed typical biotechnology outcomes while carrying slightly above-average debt.